These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1005495)

  • 1. Role of noradrenergic and dopaminergic processes in amphetamine self-administration.
    Risner M; Jones BE
    Pharmacol Biochem Behav; 1976 Oct; 5(4):477-82. PubMed ID: 1005495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of beta-phenethylamine self-administration by dog.
    Risner ME; Jones BE
    Pharmacol Biochem Behav; 1977 Jun; 6(6):689-96. PubMed ID: 263551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous self-administration of cocaine and norcocaine by dogs.
    Risner ME; Jones BE
    Psychopharmacology (Berl); 1980; 71(1):83-9. PubMed ID: 6779329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine- type reinforcement by dopaminergic agonists in the rat.
    Yokel RA; Wise RA
    Psychopharmacology (Berl); 1978 Jul; 58(3):289-96. PubMed ID: 98800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats.
    Yokel RA; Wise RA
    Psychopharmacology (Berl); 1976 Aug; 48(3):311-8. PubMed ID: 823588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of risperidone, raclopride, and ritanserin on intravenous self-administration of d-amphetamine.
    Fletcher PJ
    Pharmacol Biochem Behav; 1998 May; 60(1):55-60. PubMed ID: 9610924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys.
    Czoty PW; Martelle JL; Nader MA
    Psychopharmacology (Berl); 2010 May; 209(4):375-82. PubMed ID: 20217052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actions of amphetamine and antagonists on pupil diameter in the chronic sympathectomized dog.
    Sharpe LG; Pickworth WB; Martin WR
    Psychopharmacology (Berl); 1977 Jul; 53(2):115-20. PubMed ID: 408837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D & L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons.
    Bunney BS; Walters JR; Kuhar MJ; Roth RH; Aghajanian GK
    Psychopharmacol Commun; 1975; 1(2):177-90. PubMed ID: 1223998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration.
    Lyness WH; Friedle NM; Moore KE
    Pharmacol Biochem Behav; 1979 Nov; 11(5):553-6. PubMed ID: 531077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulus effects of d-amphetamine II: DA, NE, and 5-HT mechanisms.
    West WB; Van Groll BJ; Appel JB
    Pharmacol Biochem Behav; 1995 May; 51(1):69-76. PubMed ID: 7617735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between norepinephrine antagonists and potentiators (chlorpromazine, chlorpromazine sulfoxide and imipramine) and sympathetic amines (amphetamine and methoxamine) on the flexor reflex of the chronic spinal dog.
    Martin WR; Eades CG
    Int J Neuropharmacol; 1968 Nov; 7(6):493-501. PubMed ID: 5253333
    [No Abstract]   [Full Text] [Related]  

  • 14. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
    Brauer LH; de Wit H
    Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenergic action of amphetamine following degeneration of descending monoaminergic fibers in the spinal cord.
    Nozaki M; Bell JA; Martin WR
    Psychopharmacology (Berl); 1980 Jan; 67(1):25-9. PubMed ID: 6768076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous self-administration of d- and l-amphetamine by dog.
    Risner ME
    Eur J Pharmacol; 1975; 32(02):344-8. PubMed ID: 1171019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of noradrenergic and dopaminergic neurons in shock-induced jumping in rats.
    Nishikawa T; Tanaka M; Kohno Y; Tsuda A; Nagasaki N
    Eur J Pharmacol; 1981 May; 71(4):429-36. PubMed ID: 7250198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACTH1-24 effects on d-amphetamine self-administration and the dynamics of brain dopamine in rats.
    Leccese AP; Lyness WH
    Peptides; 1984; 5(4):659-64. PubMed ID: 6093071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of d-amphetamine and apomorphine in a new animal model of petit mal epilepsy.
    King GA; Burnham WM
    Psychopharmacology (Berl); 1980; 69(3):281-5. PubMed ID: 6774368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of central dopamine in the hyperthermia in rats produced by d-amphetamine.
    Ulus IH; Kiran BK; Ozkurt S
    Pharmacology; 1975; 13(4):309-16. PubMed ID: 1187755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.